Plavix Safety Profile & Adverse Events

Safety Profile Overview

Antiplatelet agent for ACS and stroke prevention. Pharmacogenomic considerations with CYP2C19 poor metabolizers affect drug efficacy.

Generic Name

clopidogrel

Brand Names

Plavix

Therapeutic Class

P2Y12 Inhibitor

Manufacturer

Sanofi/BMS

What Pharma Signal Tracks for Plavix

Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Plavix, including serious outcomes, hospitalizations, and deaths.
FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Plavix products.
Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.

Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.

Get Plavix Safety Data via API

One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Plavix.

curl "https://api.pharma-signal.com/drug/safety/plavix" \
  -H "X-API-Key: your_key"

# Returns risk score, adverse event counts,
# serious/death rates, recalls, and signals

Try the API API Reference

Related Safety Intelligence

Pharma Signal provides comparative analysis across therapeutic classes. Compare Plavix against other P2Y12 Inhibitor drugs, or explore the full manufacturer portfolio for Sanofi/BMS.

Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
Therapeutic class benchmarking — See how Plavix ranks within P2Y12 Inhibitor on serious event rates.
Company portfolio risk — View all drugs from Sanofi/BMS with aggregate risk exposure.
AI analyst briefs — Get a natural-language safety assessment combining all data sources.